hotspot -WSS

hotspot

author：knowledge 2025-09-29 21:25:19 - browse：3127

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Colorectal cancer study finds potential in overlooked immune cell

WSS

Long Covid research funding gets a major boost from NIH

Why don't Americans have at

Report cites 'urgent' need to recruit more diverse clinical trial participants

Phenylephrine and the overlooked value of the placebo effect

3 questions for the future of Biden's cancer moonshot

Abbott's new heart device gets FDA advisory panel nod

leisure time

hotspot

explore

Novavax promises a turnaround & Lilly roils the obesity market

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

How one medical school became remarkably diverse

The future of health care in the House

New air purifier tech could be key to improving indoor air quality

Juul documents reveal insider tactics on political lobbying

Medicare proposal to cover medical devices draws a mixed reaction

3 questions for the future of Biden's cancer moonshot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Phenylephrine and the overlooked value of the placebo effect

entertainment

FDA rejects Alnylam's heart disease treatment over insufficient data

Chemotherapy drug shortage eases slightly but still widespread

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Why Eli Lilly’s earnings didn’t quite live up to the hype

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

explore

focus

focus

entertainment